An Update on Betrixaban, The Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis.

Daryabari, Yasaman; Amreek, Fnu; Moghadamnia, Ali Akbar; Tayebi, Pouya

Daryabari, Yasaman; Amreek, Fnu; Moghadamnia, Ali Akbar; Tayebi, Pouya.

Afiliación

Daryabari Y; Department of Vascular and Endovascular Surgery, Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.
Amreek F; University of Connecticut School of Medicine, Farmington, CT.
Moghadamnia AA; Department of Pharmacology and Toxicology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
Tayebi P; Pharmaceutical Sciences Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran; and.

J Cardiovasc Pharmacol ; 83(2): 134-143, 2024 Feb 01.

Article en En | MEDLINE | ID: mdl-37728553

Asunto(s)

Anticoagulantes; Piridinas; Tromboembolia Venosa; Humanos; Anticoagulantes/efectos adversos; Tromboembolia Venosa/prevención & control; Benzamidas/farmacología; Rivaroxabán/uso terapéutico; Fibrinolíticos/uso terapéutico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridinas / Tromboembolia Venosa / Anticoagulantes Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Cardiovasc Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google